New diagnostic approaches to primary central nervous system lymphoma have been developed that may make brain biopsy unnecessary in many instances. Reduced-dose chemotherapy for non-Hodgkin's lymphoma has been shown to be advantageous in a randomized controlled trial. New agents for the treatment of Kaposi's sarcoma are available. Adoptive cellular immunotherapy has been shown to be effective in the treatment and prevention of Epstein-Barr virus-associated B-cell lymphomas in bone marrow transplant recipients, and may have promise in AIDS patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00001432-199802000-00006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!